Philip D Mosier - JoVE Visualize

Showing results (21-30 of 45) with videos related to

Pageof 5

Sort By:

Chemical Research in Toxicology|June 17, 2003

Predicting the genotoxicity of thiophene derivatives from molecular structurePhilip D Mosier, Peter C Jurs, Laura L Custer, et al.

Journal of Medicinal Chemistry|October 14, 2008

Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigationScott P Runyon, Philip D Mosier, Bryan L Roth, et al.

Bioorganic & Medicinal Chemistry|August 25, 2009

Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivityJitesh R Shah, Philip D Mosier, Bryan L Roth, et al.

Plos One|October 9, 2014

Crystal structures of influenza A virus matrix protein M1: variations on a themeMartin K Safo, Faik N Musayev, Philip D Mosier, et al.

European Journal of Medicinal Chemistry|September 7, 2014

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptorPrabhakar R Polepally, Krzysztof Huben, Eyal Vardy, et al.

Bioorganic & Medicinal Chemistry|September 24, 2013

Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonistsSaheem A Zaidi, Christopher K Arnatt, Hengjun He, et al.

Future Medicinal Chemistry|October 22, 2019

High-affinity sigma-1 (σ1) receptor ligands based on the σ1 antagonist PB212Mauro Niso, Philip D Mosier, Roberta Marottoli, et al.

Biochemistry|June 15, 2005

Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptorsFeng Yan, Philip D Mosier, Richard B Westkaemper, et al.

ACS Chemical Neuroscience|August 18, 2016

Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT3) Subunit A ReceptorsKatie Alix, Shailesh Khatri, Philip D Mosier, et al.

Bioorganic & Medicinal Chemistry Letters|June 18, 2002

Discovery of imidazole glycerol phosphate dehydratase inhibitors through 3-D database searchingBarbara A Schweitzer, Paul J Loida, Claire A CaJacob, et al.

Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:

Pageof 5

Chemical Research in Toxicology|June 17, 2003

Predicting the genotoxicity of thiophene derivatives from molecular structurePhilip D Mosier, Peter C Jurs, Laura L Custer, et al.

Journal of Medicinal Chemistry|October 14, 2008

Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigationScott P Runyon, Philip D Mosier, Bryan L Roth, et al.

Bioorganic & Medicinal Chemistry|August 25, 2009

Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivityJitesh R Shah, Philip D Mosier, Bryan L Roth, et al.

Plos One|October 9, 2014

Crystal structures of influenza A virus matrix protein M1: variations on a themeMartin K Safo, Faik N Musayev, Philip D Mosier, et al.

European Journal of Medicinal Chemistry|September 7, 2014

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptorPrabhakar R Polepally, Krzysztof Huben, Eyal Vardy, et al.

Bioorganic & Medicinal Chemistry|September 24, 2013

Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonistsSaheem A Zaidi, Christopher K Arnatt, Hengjun He, et al.

Future Medicinal Chemistry|October 22, 2019

High-affinity sigma-1 (σ1) receptor ligands based on the σ1 antagonist PB212Mauro Niso, Philip D Mosier, Roberta Marottoli, et al.

Biochemistry|June 15, 2005

Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptorsFeng Yan, Philip D Mosier, Richard B Westkaemper, et al.

ACS Chemical Neuroscience|August 18, 2016

Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT3) Subunit A ReceptorsKatie Alix, Shailesh Khatri, Philip D Mosier, et al.

Bioorganic & Medicinal Chemistry Letters|June 18, 2002

Discovery of imidazole glycerol phosphate dehydratase inhibitors through 3-D database searchingBarbara A Schweitzer, Paul J Loida, Claire A CaJacob, et al.

Pageof 5